I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 121 filers reported holding I MAB in Q1 2022. The put-call ratio across all filers is 1.75 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $31,972 | -55.6% | 10,693 | -48.7% | 0.00% | -50.0% |
| Q1 2023 | $72,068 | +39.8% | 20,829 | +68.9% | 0.00% | 0.0% |
| Q4 2022 | $51,535 | -82.0% | 12,329 | -83.3% | 0.00% | -77.8% |
| Q3 2022 | $287,000 | -66.9% | 73,858 | -4.0% | 0.01% | -65.4% |
| Q2 2022 | $867,000 | +86.9% | 76,960 | +169.1% | 0.03% | +116.7% |
| Q1 2022 | $464,000 | -55.5% | 28,602 | +30.0% | 0.01% | -55.6% |
| Q4 2021 | $1,042,000 | -37.7% | 21,994 | -4.6% | 0.03% | -47.1% |
| Q3 2021 | $1,672,000 | -22.1% | 23,066 | -9.7% | 0.05% | -21.5% |
| Q2 2021 | $2,145,000 | -8.5% | 25,554 | -47.1% | 0.06% | -17.7% |
| Q1 2021 | $2,343,000 | -5.4% | 48,347 | -8.0% | 0.08% | -21.8% |
| Q4 2020 | $2,478,000 | +521.1% | 52,550 | +518.9% | 0.10% | +405.0% |
| Q3 2020 | $399,000 | -14.0% | 8,491 | -45.3% | 0.02% | -16.7% |
| Q2 2020 | $464,000 | +79.8% | 15,516 | -21.7% | 0.02% | +41.2% |
| Q1 2020 | $258,000 | – | 19,822 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 222,136 | $293,220 | 0.32% |
| HHLR ADVISORS, LTD. | 6,909,220 | $9,120,170 | 0.20% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 310,499 | $409,859 | 0.14% |
| Maso Capital Partners Ltd | 100,000 | $132 | 0.07% |
| Diametric Capital, LP | 122,953 | $162,297 | 0.07% |
| Artal Group S.A. | 850,000 | $1,122 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 195,546 | $258 | 0.02% |
| Headlands Technologies LLC | 7,394 | $9,760 | 0.01% |
| Temasek Holdings (Private) Ltd | 566,650 | $747,978 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 39,471 | $52,102 | 0.00% |